Your browser doesn't support javascript.
loading
Weakly supervised annotation-free cancer detection and prediction of genotype in routine histopathology.
Schrammen, Peter Leonard; Ghaffari Laleh, Narmin; Echle, Amelie; Truhn, Daniel; Schulz, Volkmar; Brinker, Titus J; Brenner, Hermann; Chang-Claude, Jenny; Alwers, Elizabeth; Brobeil, Alexander; Kloor, Matthias; Heij, Lara R; Jäger, Dirk; Trautwein, Christian; Grabsch, Heike I; Quirke, Philip; West, Nicholas P; Hoffmeister, Michael; Kather, Jakob Nikolas.
Afiliación
  • Schrammen PL; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Ghaffari Laleh N; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Echle A; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Truhn D; Department of Radiology, University Hospital RWTH Aachen, Aachen, Germany.
  • Schulz V; Department of Physics of Molecular Imaging Systems, Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany.
  • Brinker TJ; Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany.
  • Brenner H; Comprehensive Diagnostic Center Aachen (CDCA), University Hospital Aachen, Aachen, Germany.
  • Chang-Claude J; Hyperion Hybrid Imaging Systems GmbH, Aachen, Germany.
  • Alwers E; Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brobeil A; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kloor M; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Heij LR; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jäger D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Trautwein C; Cancer Epidemiology Group, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Grabsch HI; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Quirke P; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • West NP; Tumor Bank Unit, Tissue Bank of the National Center for Tumor Diseases, Heidelberg, Germany.
  • Hoffmeister M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Kather JN; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
J Pathol ; 256(1): 50-60, 2022 01.
Article en En | MEDLINE | ID: mdl-34561876
ABSTRACT
Deep learning is a powerful tool in computational pathology it can be used for tumor detection and for predicting genetic alterations based on histopathology images alone. Conventionally, tumor detection and prediction of genetic alterations are two separate workflows. Newer methods have combined them, but require complex, manually engineered computational pipelines, restricting reproducibility and robustness. To address these issues, we present a new method for simultaneous tumor detection and prediction of genetic alterations The Slide-Level Assessment Model (SLAM) uses a single off-the-shelf neural network to predict molecular alterations directly from routine pathology slides without any manual annotations, improving upon previous methods by automatically excluding normal and non-informative tissue regions. SLAM requires only standard programming libraries and is conceptually simpler than previous approaches. We have extensively validated SLAM for clinically relevant tasks using two large multicentric cohorts of colorectal cancer patients, Darmkrebs Chancen der Verhütung durch Screening (DACHS) from Germany and Yorkshire Cancer Research Bowel Cancer Improvement Programme (YCR-BCIP) from the UK. We show that SLAM yields reliable slide-level classification of tumor presence with an area under the receiver operating curve (AUROC) of 0.980 (confidence interval 0.975, 0.984; n = 2,297 tumor and n = 1,281 normal slides). In addition, SLAM can detect microsatellite instability (MSI)/mismatch repair deficiency (dMMR) or microsatellite stability/mismatch repair proficiency with an AUROC of 0.909 (0.888, 0.929; n = 2,039 patients) and BRAF mutational status with an AUROC of 0.821 (0.786, 0.852; n = 2,075 patients). The improvement with respect to previous methods was validated in a large external testing cohort in which MSI/dMMR status was detected with an AUROC of 0.900 (0.864, 0.931; n = 805 patients). In addition, SLAM provides human-interpretable visualization maps, enabling the analysis of multiplexed network predictions by human experts. In summary, SLAM is a new simple and powerful method for computational pathology that could be applied to multiple disease contexts. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Neoplásicos Hereditarios / Neoplasias Encefálicas / Neoplasias Colorrectales / Inestabilidad de Microsatélites / Mutación Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Pathol Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Neoplásicos Hereditarios / Neoplasias Encefálicas / Neoplasias Colorrectales / Inestabilidad de Microsatélites / Mutación Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Pathol Año: 2022 Tipo del documento: Article País de afiliación: Alemania